Boston Scientific
996 hedge funds and large institutions have $65.7B invested in Boston Scientific in 2023 Q1 according to their latest regulatory filings, with 139 funds opening new positions, 389 increasing their positions, 320 reducing their positions, and 53 closing their positions.
162% more first-time investments, than exits
New positions opened: 139 | Existing positions closed: 53
22% more repeat investments, than reductions
Existing positions increased: 389 | Existing positions reduced: 320
9% more capital invested
Capital invested by funds: $60.4B → $65.7B (+$5.33B)
7% more funds holding
Funds holding: 930 → 996 (+66)
0.37% more ownership
Funds ownership: 91.11% → 91.48% (+0.37%)
10% less funds holding in top 10
Funds holding in top 10: 29 → 26 (-3)
24% less call options, than puts
Call options by funds: $210M | Put options by funds: $278M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$593M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$564M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$400M |
| 4 |
Neuberger Berman Group
New York
|
+$239M |
| 5 |
Holocene Advisors
New York
|
+$205M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$648M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$529M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$395M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$117M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$115M |
BSX Hedge Fund Activity: Q1 2023 in Review
996 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2023, worth a combined $65.7B — up 8.8% from $60.4B a quarter earlier.
Buyers outnumbered sellers: 139 funds opened new BSX positions and 53 closed out — a net gain of 86 holders — while 389 added to existing stakes and 320 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $593M. The largest seller was JP Morgan Chase, cutting an estimated $648M.
- 996 institutional investors held Boston Scientific (BSX) as of Q1 2023, up from 930 in Q4 2022.
- Funds reported $65.7B of Boston Scientific stock for Q1 2023, up 8.8% quarter-over-quarter.
- 139 funds opened new Boston Scientific positions in Q1 2023 and 53 closed out, a net change of +86 holders.
- The largest Boston Scientific buyer in Q1 2023 was Fidelity Investments, an estimated $593M added.
- The largest Boston Scientific seller in Q1 2023 was JP Morgan Chase, an estimated $648M sold.
Based on aggregated 13F filings for Q1 2023.